Table 1.
Assumptions around HCV infection date for HCV co-infected individuals in the UKR Register of HIV seroconverters.
Table 2.
Baseline characteristics of HIV seroconverters by HCV infection status.
Table 3.
Effect of HCV co-infection on time from HIV seroconversion to CD4<350 cells/mm3, AIDS or death by HCV infection status and HCV infection duration: UK Register of HIV seroconverters.
Fig 1.
Predicted declines in CD4 counts comparing HCV infected individuals to those with similar HIV duration without HCV infection.
Table 4.
Baseline characteristics of HIV seroconverters initiating cART by HCV status.